Home › All Companies › CBLL › Annual Report

Ceribell, Inc. (CBLL) — Annual Report

AI-Powered SEC Filing Analysis

← All CBLL filings
Latest Annual Report Filed: 2026-02-24

Key Insights

  • Ceribell, Inc. (CBLL) filed its 10-K report for the fiscal year 2025, indicating the company's continued research and development efforts in the medical device industry.
  • The company reported revenue from its EEG portal and clarity subscriptions, as well as sales of EEG recorders and headbands, suggesting ongoing product development and commercialization.
  • Ceribell has outstanding restricted stock units and stock options, which could indicate potential dilution for shareholders in the future.
Sentiment: Neutral Significance: 5/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-02-24. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for Ceribell, Inc.

Insider Trading Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.